Evidence map›Paper›PMID 28546767›Full record

ArticleJournal of pain research2017

Increase and regulation of synovial calcitonin gene-related peptide expression in patients with painful knee osteoarthritis.

Shotaro Takano, Kentaro Uchida, Gen Inoue, Atsushi Minatani, Masayuki Miyagi, Jun Aikawa, Dai Iwase, Kenji Onuma, Manabu Mukai, Masashi Takaso

Open access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shotaro TakanoDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Kentaro UchidaDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Gen InoueDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Atsushi MinataniDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Masayuki MiyagiDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Jun AikawaDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Dai IwaseDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Kenji OnumaDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Manabu MukaiDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Masashi TakasoDepartment of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies suggest that the vasodilatory neuropeptide calcitonin gene-related peptide (CGRP) is localized in the synovial tissue and may be involved in the pathology of hip and knee osteoarthritis (OA). However, the regulation and relationship between pain and CGRP expression levels in the synovial tissue of human OA patients are not fully understood.

methodsSynovial tissues were harvested from 74 participants with radiographic knee OA (unilateral Kellgren/Lawrence grades 3-4) during total knee arthroplasty. CGRP-expressing cells in the resected tissue were identified by immunohistochemical analyses. To examine CGRP expression levels, CD14-positive (CD14+) (macrophage-rich cell fraction) and CD14-negative (CD14-; fibroblast-rich cell fraction) cells were isolated from the synovial tissue. To investigate the involvement of prostaglandin E2 (PGE2) in the regulation of CGRP expression, cultured CD14- and CD14+ cells were stimulated with PGE2. In addition, CGRP expression levels in the synovial tissue of OA patients with strong/severe (visual analog scale [VAS]≥6) and mild/moderate pain (VAS<6) were compared.

resultsCGRP-positive cells were detected in the intimal lining layer and comprised both CD14- and CD14+ cells. CGRP expression in non-cultured CD14- fractions was significantly higher than that in CD14+ fractions. The expression levels of CGRP were significantly increased in cultured CD14- cell fractions treated with exogenous PGE2, compared to untreated CD14- cell fractions. In contrast, treatment with PGE2 did not increase CGRP regardless of whether or not CD14+ cells expressed CGRP. Furthermore, CGRP expression in the VAS≥6 group was also significantly higher than that in the VAS<6 group.

conclusionThese findings suggest that CGRP expression in the synovial fibroblasts is regulated by the COX-2/PGE2 pathway and that elevation of synovial CGRP levels may contribute to OA pain.

Indexed as

calcitonin gene-related peptideknee osteoarthritispainregulationsynovium

Identifiers

PMID28546767
PMCPMC5436753
OpenAlexW2612069100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.